Ectopic mediastinal parathyroid diagnosed by contrast-enhanced endoscopic ultrasound-guided fine-needle aspiration and eluate parathormone level
Open Access
- 14 January 2025
- journal article
- e videos
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E126-E127
Abstract
Primary hyperparathyroidism is defined as an elevated serum calcium with an elevated or inappropriately normal parathyroid hormone (PTH), and rarely it can be due to an ectopic mediastinal parathyroid [1]. We describe a 68-year-old woman with a new diagnosis of primary hyperparathyroidism due to a suspected mediastinal parathyroid. Laboratory tests revealed an elevated serum calcium (11.5 mg/dL [normal range 8.8–10.1]), decreased serum phosphorus (2.1 mg/dL [2.5–4.5]), high parathormone (150 pg/mL [12–72]), and hypercalciuria (313 mg/day [>250 mg/day]). The patient also had multiple co-morbidities, including atrial fibrillation, obesity, and a multinodular goiter. According to recent guidelines, parathyroidectomy was indicated [1]. We performed endoscopic ultrasound (EUS) to identify the precise location of the ectopic parathyroid, using a linear echoendoscope (GF-UCT180; Olympus Medical, Tokyo, Japan) connected to an Arietta S70 (Hitachi-Aloka, Japan) [2] [3]. We detected an ill-defined hypoechoic inhomogeneous lesion (19 × 8 mm) at 20 cm from the upper incisors on the right side of the esophagus ([Video 1]). As we deemed B-mode scanning insufficient to proceed with EUS-guided fine-needle aspiration (EUS-FNA) safely, we investigated the lesion further with contrast-enhanced EUS after injection of one vial of Sonovue (Bracco, Italy), which showed a hyperenhanced lesion [4]. EUS-FNA was then performed with a 22G needle (Expect; Boston Scientific, USA). The aspirate was diluted in 2 mL normal saline and a real-time rapid PTH assay was performed. The cytologic appearance and PTH level on the diluted eluate (>2500 pg/mL) were diagnostic of an ectopic parathyroid ([Fig. 1]). For the detection of ectopic adenomas, current guidelines [1] recommend imaging methods such as neck ultrasound, scintigraphy, positron-emission tomography, and computed tomography, which may be inconclusive in some cases. EUS-FNA and PTH testing on the eluate, which is usually more sensitive than the cytology of the specimen, should be considered. We believe that EUS-FNA is safe in these often co-morbid and frail patients, allowing appropriate referral for a major surgical intervention such as parathyroidectomy [5]. Endoscopy_UCTN_Code_CCL_1AF_2AC Article published online: 06 February 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, GermanyKeywords
This publication has 6 references indexed in Scilit:
- Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International WorkshopJournal of Bone and Mineral Research, 2020
- Interobserver agreement in contrast harmonic endoscopic ultrasoundJournal of Gastroenterology and Hepatology, 2012
- Scientific Publications in Endoscopic UltrasonographyJournal of Clinical Gastroenterology, 2011
- Endoscopic Ultrasound-Guided Fine-Needle Aspiration With Aspirate Assay to Diagnose Suspected Mediastinal Parathyroid AdenomasEndocrine Practice, 2010
- Diagnosis of Ectopic Middle Mediastinal Parathyroid Adenoma Using Endoscopic Ultrasonography-Guided Fine-Needle Aspiration with Real-Time Rapid Parathyroid Hormone AssayJournal of the American College of Surgeons, 2009
- Surgeons and Ethics: You Bet!Journal of the American College of Surgeons, 2009